Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1475 of 2228 entries
View as:

Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02265289 Org: User:
Start: 01/31/99 End: - Due: -

Safety, Tolerability and Pharmacokinetics of BI 653048 H3PO4 Oral Drinking Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02217644 Org: User:
Start: 11/30/08 End: - Due: -

Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02171663 Org: User:
Start: 03/31/04 End: - Due: -

GLORIA-AF Registry Program (Phase II/III)

Phase: N/A Priority: Normal
NCT ID: NCT01937377 Org: User:
Start: 09/02/13 End: 04/15/19 Due: 04/15/20

Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran

Phase: N/A Priority: Normal
NCT ID: NCT01595854 Org: User:
Start: 05/31/12 End: 06/30/12 Due: 06/30/13

Clinical Trial to Assess Pharmacodynamic Effects on Segmental Endotoxin Induced Inflammatory Response of BI 1026706 Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02657408 Org: User:
Start: 03/11/16 End: 03/13/17 Due: 03/13/18

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01306214 Org: User:
Start: 02/28/11 End: 04/30/13 Due: 04/30/14

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT02199886 Org: User:
Start: 07/31/98 End: - Due: -

Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

Phase: N/A Priority: Normal
NCT ID: NCT04926233 Org: User:
Start: 11/15/19 End: 04/14/20 Due: 04/14/21

Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT03717012 Org: User:
Start: 11/15/18 End: 06/10/20 Due: 06/10/21

12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00789035 Org: User:
Start: 10/31/08 End: - Due: -

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00144157 Org: User:
Start: 06/30/03 End: 07/31/06 Due: 07/31/07

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231424 Org: User:
Start: 01/31/99 End: - Due: -

Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02438696 Org: User:
Start: 05/31/15 End: 08/31/15 Due: 08/31/16

Assessment of the Effect of BI 201335 on the QT Interval in Healthy Female and Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182310 Org: User:
Start: 06/30/08 End: - Due: -

An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.

Phase: N/A Priority: Normal
NCT ID: NCT00002194 Org: User:
Start: - End: - Due: -

Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT02242318 Org: User:
Start: 09/30/01 End: - Due: -

Dose Finding Study in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00122434 Org: User:
Start: 07/31/05 End: - Due: -

FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH)

Phase: N/A Priority: Normal
NCT ID: NCT02244294 Org: User:
Start: 03/31/01 End: - Due: -

A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT05469646 Org: User:
Start: 08/03/22 End: 12/27/22 Due: 12/27/23

A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04426851 Org: User:
Start: 07/13/20 End: 10/12/20 Due: 10/12/21

Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

Phase: N/A Priority: Normal
NCT ID: NCT01139658 Org: User:
Start: 08/31/10 End: 09/30/12 Due: 09/30/13

Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT01100073 Org: User:
Start: 02/29/08 End: - Due: -

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT05372367 Org: User:
Start: 08/11/22 End: 04/29/25 Due: 04/29/26

A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT06139315 Org: User:
Start: 06/02/22 End: 06/07/23 Due: 06/07/24